Genital herpes vaccines - Cause for cautious optimismg

Sexual Health

Volumn 3, Issue 1, 2006, Pages 1-4

  Haddow, Lewis J ^a   Mindel, Adrian ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES SIMPLEX VACCINE; SIMPLIRIX;

CHILD HEALTH; CLINICAL TRIAL; DRUG EFFICACY; GENITAL HERPES; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INFECTION PREVENTION; INFECTION RATE; REVIEW; SEROPREVALENCE; SEX DIFFERENCE; SEXUAL TRANSMISSION; TH1 CELL; TH2 CELL; VIRION; VIRUS SHEDDING; VIRUS TRANSMISSION;

HERPES GENITALIS; HERPES SIMPLEX VIRUS VACCINES; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HUMANS; RANDOMIZED CONTROLLED TRIALS; VACCINATION;

EID: 33144479537     PISSN: 14485028     EISSN: None     Source Type: Journal    
DOI: 10.1071/SH05041     Document Type: Review

References (26)

1. Simmons A. Clinical manifestations and treatment considerations of herpes simplex virus infection. J Infect Dis 2002; 186 (Suppl 1): S71-7. doi: 10.1086/342967
2. Mindel A, Marks C. Psychological symptoms associated with genital herpes infections. Epidemiology and approaches to management. CNS Drugs 2005; 19: 303-12.
3. Weiss HA, Buvé A, Robinson NJ, Van Dyck E, Kahindo M, Anagonou S, et al. Study group on heterogeneity of HIV epidemics in African cities. The epidemiology of HSV-2 infection and its association with HIV infection in four African populations. AIDS 2001; 15 (Suppl 4): S97-108. doi: 10.1097/00002030- 200108004-00011
4. Stanberry LR, Cunningham AL, Mindel A, Scott LL, Spruance SL, Aoki FY, et al. Prospects for control of herpes simplex virus disease through immunization. Clin Infect Dis 2000; 30: 549-66. doi: 10.1086/313687
5. Stanberry LR, Spruance SL, Cunningham AL, Bernstein DI, Mindel A, Sacks S, et al. GlaxoSmithKline herpes vaccine efficacy study group. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002; 347: 1652-61. doi: 10.1056/NEJMoa011915
6. Corey L, Langenberg AG, Ashley R, Sekulovich RE, Izu AE, Douglas JM Jr, et al. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA 1999; 282: 331-40. doi: 10.1001/jama.282.4.331
7. Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999; 341: 1432-8. doi: 10.1056/ NEJM199911043411904
8. Langenberg A, Benedetti J, Jenkins J, Ashley R, Winter C, Corey L. Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection. Ann Intern Med 1989; 110: 882-7.
9. Posavad CM, Koelle DM, Corey L. High frequency of CD8+ cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes. J Virol 1996; 70: 8165-8.
10. Mikloska Z, Cunningham AL. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes. J Gen Virol 1998; 79: 353-61.
11. Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995; 333: 770-5. doi: 10.1056/NEJM199509213331205
12. Mindel A, Taylor R, Taylor J, Marks C, Shaw J, Cunningham AL. Prevalence of infection with HSV 1 and 2 in Australia: a nationwide population-based survey. Abstract presented at 16th International Society for Sexually Transmitted Disease Research (ISSTDR) meeting, July 2005, Amsterdam, Netherlands.
13. Vyse AJ, Gay NJ, Slomka MJ, Gopal R, Gibbs T, Morgan-Capner P, et al. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect 2000; 76: 183-7. doi: 10.1136/sti.76.3.183
14. Tran T, Druce JD, Carton MC, Kelly H, Birch CJ. Changing epidemiology of genital herpes simplex virus infection in Melbourne, Australia, between 1980 and 2003. Sex Transm Infect 2004; 80: 277-9. doi: 10.1136/sti.2004.009753
15. Haddow LJ, Dave B, Mindel A, Chung C, Marks C, Dwyer D. Increase in rates of herpes simplex virus type 1 (HSV-1) as a cause of genital herpes between 1979 and 2003. Abstract presented at Australasian Sexual Health Conference, August 2005, Hobart, Australia.
16. Auslander BA, Rosenthal SL, Succop PA, Mills LM, Stanberry LR, Bernstein DI. Gender-specific predictors of genital herpes vaccine acceptance in a college population. Int J STD AIDS 2005; 16: 27-30. doi: 10.1258/0956462052932593
17. Mays RM, Sturm LA, Zimet GD. Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med 2004; 58: 1405-13. doi: 10.1016/S0277-9536(03)00335-6
18. Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 2003; 30: 797-800.
19. Breinig MK, Kingsley LA, Armstrong JA, Freeman DJ, Ho M. Epidemiology of genital herpes in Pittsburgh: serologic, sexual, and racial correlates of apparent and inapparent herpes simplex infections. J Infect Dis 1990; 162: 299-305.
20. Pebody RG, Andrews N, Brown D, Gopal R, de Melker H, François G, et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect 2004; 80: 185-91. doi: 10.1136/sti.2003.005850
21. Weiss H. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes 2004; 11 (Suppl 1): 24A-35A.
22. Mikloska Z, Bosnjak L, Cunningham AL. Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1. J Virol 2001; 75: 5958-64. doi: 10.1128/JVI.75.13.5958-5964.2001
23. Schacker T, Ryncarz AJ, Goddard J, Diem K, Shaughnessy M, Corey L. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA 1998; 280: 61-6. doi: 10.1001/jama.280.1.61
24. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002; 185: 45-52. doi: 10.1086/338231
25. del Mar Pujades Rodriguez M, Obasi A, Mosha F, Todd J, Brown D, Changalucha J, et al. Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania. AIDS 2002; 16: 451-62. doi: 10.1097/00002030-200202150-00018
26. Cunningham AL, Dwyer DE. The pathogenesis underlying the interaction of HIV and herpes simplex virus after co-infection. J HIV Ther 2004; 9: 9-13.